Journey Medical Corporation/ US48115J1097 /
2024-04-26 10:00:00 PM | Chg. -0.1000 | Volume | Bid10:49:02 PM | Ask10:49:02 PM | High | Low |
---|---|---|---|---|---|---|
3.4000USD | -2.86% | 64,845 Turnover: 206,007.8223 |
3.4200Bid Size: 900 | 3.6800Ask Size: 1,000 | 3.5400 | 3.3600 |
GlobeNewswire
04-25
Journey Medical Corporation to Present at the Planet MicroCap Showcase: Vegas 2024
GlobeNewswire
03-21
Journey Medical Corporation Reports Full-Year 2023 Financial Results and Recent Corporate Highlights
GlobeNewswire
03-18
Journey Medical Corporation Announces U.S. FDA Acceptance of New Drug Application for DFD-29 for the...
GlobeNewswire
03-15
Journey Medical Corporation to Announce Year End 2023 Financial Results on March 21, 2024
GlobeNewswire
03-11
Journey Medical Corporation Announces Presentation of Data from Phase 1 Clinical Trial Assessing the...
GlobeNewswire
01-05
Journey Medical Corporation Submits New Drug Application to FDA for DFD-29 to Treat Rosacea
GlobeNewswire
01-02
Journey Medical Corporation Secures Credit Facility with SWK Holdings for up to $20 Million
GlobeNewswire
2023-12-06
Journey Medical Corporation Announces Successful Completion of Pre-NDA Meeting with the FDA for DFD-...
GlobeNewswire
2023-11-14
Fortress Biotech Reports Third Quarter 2023 Financial Results and Recent Corporate Highlights
GlobeNewswire
2023-11-07
Journey Medical Corporation Reports Third Quarter 2023 Financial Results and Recent Corporate Highli...
GlobeNewswire
2023-10-31
Journey Medical Corporation to Announce Third Quarter 2023 Financial Results on November 7, 2023
GlobeNewswire
2023-10-20
Journey Medical Corporation Announces Data from Bioavailability Study of DFD-29 (Minocycline Hydroch...
GlobeNewswire
2023-09-06
Journey Medical Corporation Enters into an Exclusive License Agreement with Maruho Co., Ltd. for Qbr...
GlobeNewswire
2022-03-28
Fortress Biotech Reports Record 2021 Financial Results and Recent Corporate Highlights
GlobeNewswire
2022-03-23
Journey Medical Corporation Reports Full-Year 2021 Financial Results and Recent Corporate Highlights
GlobeNewswire
2022-03-18
Journey Medical Corporation to Release Year End 2021 Financial Results and Provide Corporate Update ...
GlobeNewswire
2022-03-17
Journey Medical Corporation Announces First Patient Dosed in Phase 3 Clinical Trial Evaluating DFD-2...
GlobeNewswire
2022-02-11
QBREXZA® (Rapifort® Wipes 2.5%) Receives Manufacturing and Marketing Approval in Japan Triggering $2...